Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Endocrinol Metab ; 94(2): 421-7, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19001515

RESUMO

CONTEXT: Studies have shown that labor occurs primarily in the night/morning hours. Recently, we identified the human myometrium as a target for melatonin (MEL), the neuroendocrine output signal coding for circadian night. OBJECTIVE: The purpose of this study was to determine the effects of MEL on contractility and the contractile machinery in telomerase-immortalized human myometrial cells. DESIGN: To ascertain the effect of MEL on myometrial contractility in vitro, we performed gel retraction assays with cells exposed to iodomelatonin +/- oxytocin (OT). The effects of iodomelatonin on gap junctions were also investigated. Additionally, expression levels of the type 2 MEL receptor (MT2R) were assessed in myometrial biopsies from term pregnant women with or without labor. RESULTS: MEL was found to synergistically enhance OT-induced contractility via the MT2R, which is coupled to a protein kinase C-dependent increase in phosphorylation of the myosin light chain protein. MT2R expression was markedly elevated in samples from pregnant women who had entered labor, as compared to matched nonlaboring pregnant women. MEL increased expression of the gap junction protein, connexin 43. In vitro dye spread assays showed that MEL-treated cells displayed substantially increased intercellular coupling. Increases in connexin 43 mRNA and cell to cell coupling were also found to be mediated via the MT2R in a protein kinase C-dependent manner. CONCLUSIONS: MEL synergizes with OT to promote myometrial cell contractions and to facilitate gap junction activity in vitro. Such a synergy in vivo would promote coordinated and forceful contractions of the late term pregnant uterus necessary for parturition.


Assuntos
Melatonina/farmacologia , Miócitos de Músculo Liso/efeitos dos fármacos , Miométrio/efeitos dos fármacos , Ocitocina/farmacologia , Células Cultivadas , Conexina 43/genética , Conexina 43/metabolismo , Sinergismo Farmacológico , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Trabalho de Parto/metabolismo , Trabalho de Parto/fisiologia , Melatonina/metabolismo , Modelos Biológicos , Miócitos de Músculo Liso/fisiologia , Miométrio/metabolismo , Miométrio/fisiologia , Ocitocina/metabolismo , Parto/metabolismo , Parto/fisiologia , Gravidez , Receptor MT1 de Melatonina/metabolismo , Receptor MT2 de Melatonina/metabolismo , Receptores de Ocitocina/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Contração Uterina/efeitos dos fármacos , Contração Uterina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA